ZA988941B - Conjugated polypeptides for treating Herpes Simples virus, compositions and vaccines containing same and uses thereof for treatment or prevention of Herpes Simplex virus and as diagnostic tool and in diagnostic kit. - Google Patents

Conjugated polypeptides for treating Herpes Simples virus, compositions and vaccines containing same and uses thereof for treatment or prevention of Herpes Simplex virus and as diagnostic tool and in diagnostic kit.

Info

Publication number
ZA988941B
ZA988941B ZA9808941A ZA988941A ZA988941B ZA 988941 B ZA988941 B ZA 988941B ZA 9808941 A ZA9808941 A ZA 9808941A ZA 988941 A ZA988941 A ZA 988941A ZA 988941 B ZA988941 B ZA 988941B
Authority
ZA
South Africa
Prior art keywords
virus
prevention
compositions
treatment
diagnostic
Prior art date
Application number
ZA9808941A
Other languages
English (en)
Inventor
Daniel H Zimmerman
Kenneth S Rosenthal
Original Assignee
Cel Sci Corp
Univ Northeastern Ohio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cel Sci Corp, Univ Northeastern Ohio filed Critical Cel Sci Corp
Publication of ZA988941B publication Critical patent/ZA988941B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9808941A 1997-09-30 1998-09-30 Conjugated polypeptides for treating Herpes Simples virus, compositions and vaccines containing same and uses thereof for treatment or prevention of Herpes Simplex virus and as diagnostic tool and in diagnostic kit. ZA988941B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6042297P 1997-09-30 1997-09-30

Publications (1)

Publication Number Publication Date
ZA988941B true ZA988941B (en) 2001-07-02

Family

ID=22029372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9808941A ZA988941B (en) 1997-09-30 1998-09-30 Conjugated polypeptides for treating Herpes Simples virus, compositions and vaccines containing same and uses thereof for treatment or prevention of Herpes Simplex virus and as diagnostic tool and in diagnostic kit.

Country Status (7)

Country Link
US (1) US6572860B1 (ja)
EP (1) EP1030819A4 (ja)
JP (1) JP2001518455A (ja)
AU (1) AU1065099A (ja)
CA (1) CA2304665A1 (ja)
WO (1) WO1999016710A1 (ja)
ZA (1) ZA988941B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
AU4705201A (en) * 1999-10-27 2001-06-25 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
US7199216B1 (en) * 1999-10-27 2007-04-03 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
JP2003514828A (ja) * 1999-10-27 2003-04-22 セル−サイ・コーポレーシヨン 自己免疫および移植組織に関連する宿主対移植片症状の処置に有用なペプチド構築物の調製法および組成物
EP1598370A3 (en) * 1999-10-27 2006-05-10 Cel-Sci Corporation Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
US7259232B1 (en) * 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
EP1476177A4 (en) * 2002-01-23 2005-10-05 Cel Sci Corp PEPTIDE CONSTRUCTS FOR TREATING A DISEASE
WO2003061589A2 (en) * 2002-01-23 2003-07-31 Cel-Sci Corporation Methods for treating diseases or conditions with peptide constructs
EP2289547B1 (en) * 2003-09-12 2015-12-16 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
CN1301749C (zh) * 2005-12-09 2007-02-28 复旦大学 抗单纯疱疹病毒－2感染的多表位dna疫苗及其制备方法
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US10179174B2 (en) 2011-05-25 2019-01-15 Cel-Sci Corp. Method for inducing an immune response and formulations thereof
WO2012162565A2 (en) * 2011-05-25 2012-11-29 Cel-Sci Corporation Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
EP3294324A1 (en) 2015-05-13 2018-03-21 Agenus Inc. Vaccines for treatment and prevention of cancer
TW202012430A (zh) 2018-04-26 2020-04-01 美商艾吉納斯公司 熱休克蛋白質－結合之胜肽組成物及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE130197T1 (de) * 1988-06-14 1995-12-15 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.

Also Published As

Publication number Publication date
EP1030819A4 (en) 2001-11-21
CA2304665A1 (en) 1999-04-08
JP2001518455A (ja) 2001-10-16
AU1065099A (en) 1999-04-23
US6572860B1 (en) 2003-06-03
EP1030819A1 (en) 2000-08-30
WO1999016710A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
ZA988941B (en) Conjugated polypeptides for treating Herpes Simples virus, compositions and vaccines containing same and uses thereof for treatment or prevention of Herpes Simplex virus and as diagnostic tool and in diagnostic kit.
ZA975211B (en) Compositions and methods for administering borrelia DNA.
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HK1019560A1 (en) Formulation for use in the prevention of pathogen induced diseases including hiv and hsv.
AU2790199A (en) Biochemical compositions used in human treatment
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
ZA977513B (en) Skin tanning compositions and method.
GR990100140A (el) Νεες ενωσεις
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
GB9608488D0 (en) Compositions, processes and uses
GB9608485D0 (en) Compositions, processes and uses
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
EP1037918A4 (en) METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
HK1032534A1 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU5331200A (en) Methods and compositions for treating raynaud's phenomenon and scleroderma
ZA97224B (en) Process for recovering minerals and compositions for use in this.
GB9608489D0 (en) Compositions, processes and uses
AU5974999A (en) Hair treatment composition, method and use
GB9706293D0 (en) Compositions, processes and uses
HU9903098D0 (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
GB9608493D0 (en) Compositions, processes and uses
GB9608487D0 (en) Compositions, processes and uses